Use app for best experience!
Available for Android Device.

Concord Biotech Limited IPO Detail

Concord Biotech Limited IPO Detail

Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.

Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.

The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.

Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.

Company Promoters

IPO Details

IPO Opening DateAug 04, 2023
IPO Closing DateAug 08, 2023
Issue TypeBook Built Issue IPO
Face Value₹1 per equity share
IPO Price ₹705 - 741 per equity share
Market Lot20 Shares
Min Order Quantity20 Shares
Listing AtBSE, NSE
Issue Size₹1,551.00 Cr
Fresh Issue-
Offer for Sale₹1,551.00 Cr
Retail Portion 35%

IPO Subscription (Bidding Detail)

Day 1 0.00x 0.00x 0.00x - 0.00x
Day 2 0.00x 0.00x 0.00x - 0.00x
Day 3 0.01x 1.01x 0.72x - 0.58x
Day 4 1.61x 5.22x 2.27x - 2.72x
Day 5 67.67x 16.99x 3.78x - 24.86x

IPO Tentative Timetable

The Concord Biotech Limited IPO open date is Aug 04, 2023, and the close date is Aug 08, 2023. The issue may list on Aug 18, 2023.

IPO Open DateAug 04, 2023
IPO Close DateAug 08, 2023
Basis of Allotment DateAug 11, 2023
Initiation of RefundsAug 14, 2023
Credit of Shares to Demat AccountAug 17, 2023
IPO Listing DateAug 18, 2023

IPO Lot Size

The Concord Biotech Limited IPO market lot size is 20 shares. A retail-individual investor can apply for up to 13 lots (260 shares or ₹192660).

ApplicationLotsSharesAmount (Cut-off)

IPO Promoter Holding

Pre Issue Share Holding44.08%
Post Issue Share Holding44.08%

Company Financials:

For the year/period ended (₹ in Cr.)

Financial Year Total Assets Total Revenue Profit After Tax
31-Mar-21 1182.55 630.75 234.89
31-Mar-22 1312.80 736.35 174.93
31-Mar-23 1513.98 888.48 240.08

Objects of the Issue:

The objectives of the Offer are to:

  1. Achieve the benefits of listing the Equity Shares on the Stock Exchanges and
  2. Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.

Concord Biotech Limited IPO Registrar:

Link Intime India Private Ltd

Concord Biotech Limited IPO Lead Manager(s):

Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited Jefferies India Private Limited

Company Contact Information:

Concord Biotech Limited


Trasad Road Dholka,

Ahmedabad – 382225